# Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury

> **NCT03139682** · — · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 2 (actual)

## Conditions studied

- Traumatic Brain Injury
- Blood Brain Barrier Defect

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03139682
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-03
- **Primary completion:** 2019-08-03
- **Final completion:** 2021-08-03
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139682, "Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03139682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*